Nilesh Kumar - Net Worth and Insider Trading

Nilesh Kumar Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nilesh Kumar owns 3 companies in total, including Checkmate Pharmaceuticals Inc (CMPI) , Morphic Holding Inc (MORF) , and Milestone Pharmaceuticals Inc (MIST) .

Click here to see the complete history of Nilesh Kumar’s form 4 insider trades.

Insider Ownership Summary of Nilesh Kumar

Ticker	Comapny	Transaction Date	Type of Owner
CMPI	Checkmate Pharmaceuticals Inc	2020-08-06	director
MORF	Morphic Holding Inc	2019-06-26	director
MIST	Milestone Pharmaceuticals Inc	2019-05-08	director

Nilesh Kumar Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Nilesh Kumar Ownership Network

Ownership Network List of Nilesh Kumar

No Data

Ownership Network Relation of Nilesh Kumar

Nilesh Kumar Owned Company Details

What does Checkmate Pharmaceuticals Inc do?

Who are the key executives at Checkmate Pharmaceuticals Inc?

Nilesh Kumar is the director of Checkmate Pharmaceuticals Inc. Other key executives at Checkmate Pharmaceuticals Inc include 10 percent owner Venbio Global Strategic Fund Ii L.p. , director & Chief Executive Officer Alan Bash , and 10 percent owner Novo Holdings A/s .

Checkmate Pharmaceuticals Inc (CMPI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Checkmate Pharmaceuticals Inc (CMPI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Checkmate Pharmaceuticals Inc (CMPI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Checkmate Pharmaceuticals Inc (CMPI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Checkmate Pharmaceuticals Inc Insider Transactions

No Available Data

What does Morphic Holding Inc do?

Who are the key executives at Morphic Holding Inc?

Nilesh Kumar is the director of Morphic Holding Inc. Other key executives at Morphic Holding Inc include VP Finance and Ops & Secretary Farrell Robert E Jr , General Counsel and Secretary William Devaul , and Chief Scientific Officer Bruce Rogers .

Morphic Holding Inc (MORF) Insider Trades Summary

Over the past 18 months, Nilesh Kumar made no insider transaction in Morphic Holding Inc (MORF). Other recent insider transactions involving Morphic Holding Inc (MORF) include a net sale of 47,136 shares made by Praveen P. Tipirneni , a net sale of 26,167 shares made by William Devaul , and a net sale of 69,977 shares made by Marc Schegerin .

In summary, during the past 3 months, insiders sold 0 shares of Morphic Holding Inc (MORF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 214,955 shares of Morphic Holding Inc (MORF) were sold and 4,776 shares were bought by its insiders, resulting in a net sale of 210,179 shares.

Morphic Holding Inc (MORF)'s detailed insider trading history can be found in Insider Trading Tracker table.

Morphic Holding Inc Insider Transactions

No Available Data

What does Milestone Pharmaceuticals Inc do?

Who are the key executives at Milestone Pharmaceuticals Inc?

Nilesh Kumar is the director of Milestone Pharmaceuticals Inc. Other key executives at Milestone Pharmaceuticals Inc include Chief Medical Officer David Bharucha , 10 percent owner Roderick Wong , and 10 percent owner Rtw Investments, Lp .

Milestone Pharmaceuticals Inc (MIST) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Milestone Pharmaceuticals Inc (MIST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Milestone Pharmaceuticals Inc (MIST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Milestone Pharmaceuticals Inc (MIST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Milestone Pharmaceuticals Inc Insider Transactions

No Available Data

Nilesh Kumar Mailing Address

Above is the net worth, insider trading, and ownership report for Nilesh Kumar. You might contact Nilesh Kumar via mailing address: C/o Milestone Pharmaceuticals, Inc., 1111 Dr. Frederik-philips Blvd, Ste 420, Montr?al A8 H4m 2x6.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.